Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/28/2025

Laboratory Tests for Perimenopause Diagnosis and Management

Core Laboratory Tests

  • For perimenopause diagnosis and management, laboratory evaluation should include estradiol, follicle-stimulating hormone (FSH), luteinizing hormone (LH), and prolactin, as clinically indicated. 1, 2
  • Estradiol, FSH, and LH should be measured during the early follicular phase (days 3-6 of the menstrual cycle) for accurate assessment. 2, 3
  • FSH is not a reliable marker of menopausal status alone, especially in women with prior chemotherapy, pelvic radiation exposure, or those on tamoxifen. 1, 2
  • Serial estradiol levels can be useful to determine return of ovarian function in perimenopausal women who have become amenorrheic and later develop bleeding. 1, 2
  • Prolactin should be measured to rule out hyperprolactinemia as a cause of menstrual irregularity. 2, 3

Additional Tests Based on Clinical Presentation

  • Thyroid function tests should be performed to rule out thyroid disease that may mimic menopausal symptoms. 1, 2
  • Fasting glucose/insulin levels should be checked if insulin resistance is suspected, particularly with weight gain. 3
  • Anti-Müllerian hormone (AMH) may provide additional information on ovarian status and reserve, though it should be interpreted with caution in women under age 25. 4, 5
  • Inhibin levels may provide supplementary information on ovarian status but are not reliable alone. 1, 2
  • Testosterone levels should be measured if hirsutism or other signs of hyperandrogenism are present. 3

Timing and Interpretation Considerations

  • Laboratory tests should be performed without hormonal contraception or hormone replacement therapy for accurate assessment. 6
  • FSH fluctuates significantly during perimenopause and a single elevated value does not confirm menopause. 1, 2
  • For women with irregular cycles, testing should be performed on day 3-6 of the cycle when possible. 3

Clinical Correlation

  • Laboratory results should be interpreted in conjunction with menstrual history and symptoms. 2, 7
  • Menstrual irregularity (cycles <23 days or >35 days) is a key clinical indicator of perimenopause. 3
  • Common perimenopausal symptoms requiring assessment include vasomotor symptoms, sleep disturbances, mood changes, and sexual dysfunction. 7
  • Symptoms alone are not diagnostic of perimenopause and require laboratory confirmation when making management decisions. 7

Pitfalls and Caveats

  • A normal FSH level does not rule out perimenopause, as levels fluctuate widely during this transition. 1, 2
  • AMH levels have wide normal ranges in young women and should not be used alone for diagnosis. 4, 5

When to Refer

  • Endocrinology or gynecology referral is indicated for delayed puberty, persistently abnormal hormone levels, or hypogonadism. 8, 6
  • Reproductive endocrinology consultation is recommended for infertility evaluation or fertility preservation concerns. 8, 9
  • Consider specialist referral for severe or persistent symptoms affecting quality of life. 7

REFERENCES

1

survivorship, version 2.2017, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2017

2

survivorship, version 2.2017, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2017